World-first study from UNSW to reveal link between dementia and alcohol

Health Industry Hub | February 7, 2020 |
[Total: 1    Average: 4/5]

Clarifying the relationship between alcohol use and dementia is just one of 19 new projects that will share in $1.5 million in grants to conduct ground-breaking dementia research.

Dr Louise Mewton from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) was awarded a $75,000 Dementia Australia Research Foundation Pilot Grant, sponsored by the Dementia Centre for Research Collaboration, and will use the funding to clarify the relationship between low to moderate alcohol use and the risk of dementia.

“This world-first study combines innovative, state-of the-art research methods to address two of the largest contributors to the global disease burden: dementia and alcohol use,” she said.

“To date, the relationships between these two key causes of death and disability have been under-researched and overlooked. It is critical that we have a better understanding of how alcohol use is related to age-related diseases such as dementia.

“This research will uncover innovative new avenues for dementia prevention through the development of age appropriate, evidence-based recommendations on the number of standard drinks per week associated with minimal dementia risk.”

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

The Chair of the Dementia Australia Research Foundation, Professor Graeme Samuel AC, said the grants provided support to early and mid-career researchers who want to make a difference in the field of dementia.

“This next generation of talented researchers will be among those tackling some of the biggest challenges in this field. These grants provide vital insights into reducing dementia risk, improving accurate and timely diagnoses and establishing treatment and care options for people who live with dementia,” he said.

“With the number of people living with dementia expected to increase to almost 1.1 million by 2058, research into dementia is now more urgent than ever.

“Further, the broad range of projects supported, including nanotechnology, hip fracture prevention, enhancing cognition with exercise and personalising care through music, reflect the increased diversity and quality of research in the dementia space across Australia.

“This would not be possible without the support of our most valued donors and partnerships with the Dementia Centre for Research Collaboration and the Australian Association of Gerontology Research Trust,” he concluded.

Suppliers & Service Providers: Enhance business visibility, differentiate your brand and maximise your reach. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Discover our unique digital media solutions with superior open rates and click through rates.

You may also like ANZUP’s trial recognised globally as transformative in prostate cancer treatment

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Marketing & Strategy

Marketing Pharma Biotech Healthcare - PRIME Awards 2020 finalists announced

PRIME Awards 2020 finalists announced

Health Industry Hub | August 7, 2020 |

The finalists for PRIME Awards 2020 have been named, with winners to be announced via a virtual ceremony on Thursday […]


News & Trends - Pharmaceuticals

Pharma News - New Ventolin inhalers with dose counter reimbursed on the PBS

New Ventolin inhalers with dose counter reimbursed on the PBS

Health Industry Hub | August 7, 2020 |

Pharma News: GSK Australia is pleased to announce that a dose counter has been added to VENTOLIN (salbutamol sulfate) metered […]


News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]